Ipamorelin
Price range: $49.00 through $99.00 USD
Ipamorelin is a synthetic pentapeptide growth-hormone secretagogue. Supplied for in-vitro laboratory research. Each lot is supplied with its own Certificate of Analysis.
| Form and size | Lyophilized vial |
- Certificate of Analysis for every lot
- HPLC and mass spectrometry testing for every lot
- Lot number on every vial and report
- Protective, discreet packaging
Description
About this material
Ipamorelin is a synthetic pentapeptide growth-hormone secretagogue. MICROGRAMBIO supplies Ipamorelin as a lyophilized powder in a sealed vial for in-vitro laboratory research. Each lot comes with its own Certificate of Analysis, so you can check the identity and the results for the exact vial you receive.
Research context
In the laboratory literature, Ipamorelin is discussed in work on ghrelin-receptor signalling and growth-hormone release in cell-based assays. Researchers use it as a tool to examine these systems in cell-based and other in-vitro models.
Published work comes from many laboratories that use different models, methods and conditions, and a result in one system does not carry over to another. Nothing on this page describes an effect in people or animals. Review the primary literature when you design your own study.
Research focus
- Ghrelin-receptor signalling
- Growth-hormone release in cell-based assays
- Receptor selectivity of growth-hormone secretagogues
What you receive
- A sealed vial of lyophilized powder, in the size you choose above
- A Certificate of Analysis for the lot, with the testing methods and results
- A lot number printed on the vial and on the report
- Protective, discreet packaging
Handling and documentation
Follow the storage instructions on the label and on the report for your lot, together with your laboratory's own procedures. Keep the vial sealed until you need it, and record the lot number, the date you received it and your storage conditions in your laboratory notes. If you need help reading the report, use the guides below or contact us with your order and lot numbers.
Related reading
How to read a peptide Certificate of Analysis · HPLC explained · Storage and handling basics
Specifications
| Size | 5 mg, 10 mg, 15 mg, 20 mg |
|---|---|
| Material type | Peptide |
| Form | Lyophilized powder in a sealed vial |
| Storage | As stated on the label and the report for your lot |
For laboratory research use only. Not for human or animal consumption.
Key features
- Certificate of Analysis supplied for every lot
- Testing methods and results listed on the lot report
- Lot number printed on the vial and on the report
- Supplied as a sealed lyophilized vial
- Four vial sizes: 5, 10, 15 and 20 mg
- Protective, discreet packaging
- For laboratory research use only
How this lot of Ipamorelin is verified
Identity
Mass spectrometry measures the molecular weight of the material so you can confirm the compound in the vial matches the label.
Purity
HPLC shows how much of the sample is the target peptide. The result is written into the report for your lot.
Documentation
The Certificate of Analysis is tied to your lot number. Compare it with the label before you use the material. See our testing process.
Storage and handling
Follow the storage instructions on the label and on the report for your lot, together with your laboratory's own procedures. As general laboratory practice, lyophilized material is kept sealed, dry, protected from light and cold. Record dates and conditions in your laboratory notes.
Questions about Ipamorelin
Is Ipamorelin for human or animal use?
No. Ipamorelin is supplied for laboratory research use only. It is not a drug, is not for human or animal consumption, and is not intended to diagnose, treat, cure or prevent any condition.
Where do I find the lot number and report?
The lot number is printed on the vial label. The Certificate of Analysis for the current lot is linked on this page, and your order confirmation and account show the lot you received.
How is Ipamorelin tested?
Each lot is analysed using HPLC for purity and mass spectrometry for identity, and the results are written into the report for that lot.
Who can buy Ipamorelin?
Qualified researchers and laboratories aged 21 or over. You confirm this when you enter the site and again at checkout.
Where do you ship?
Delivery options and countries are shown at checkout.
More answers on our FAQ page.






Elizabeth Diaz –
If you are looking to stack complementary peptides, pairing Ipamorelin with CagriSema (Cagrilintide + Semaglutide Combo) is an absolute winner. Ipamorelin shines for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and when stacked with CagriSema (Cagrilintide + Semaglutide Combo), you gain the additional benefit of targeting dual satiety and hunger pathways for potent, comprehensive body weight management. Reconstitution was smooth and instantaneous.
Sharon Wright –
This combination of Ipamorelin and Retatrutide + Cagrilintide Combo exceeded expectations in our trial run. The inclusion of Ipamorelin was vital for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Retatrutide + Cagrilintide Combo amplified overall outcomes by delivering unmatched weight loss, appetite suppression, and metabolic energy balance. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
Christopher Moore –
Exceptional dual protocol. Using Ipamorelin in conjunction with Semaglutide maximized total trial efficiency. Ipamorelin was key for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and Semaglutide ensured effectively reducing appetite, suppressing cravings, and improving glycemic metrics. The batch purity report matched our independent verification completely.
Susan Harris –
Stacking Ipamorelin and Tesamorelin provides a complete, well-rounded protocol. Ipamorelin acts as a baseline by providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, whereas Tesamorelin adds synergistic value through targeting visceral abdominal fat reduction, stimulating endogenous growth hormone release, and elevating IGF-1. Both vials dissolved effortlessly without residue.
Rebecca Walker –
This combination of Ipamorelin and MOTS-c exceeded expectations in our trial run. The inclusion of Ipamorelin was vital for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while MOTS-c amplified overall outcomes by promoting AMPK activation, metabolic balance, cellular energy production, and exercise capacity. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
Kevin Jackson –
Our research team ran a 4-week protocol testing Ipamorelin together with Mazdutide. The results were noticeable from week one: Ipamorelin targeted providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Mazdutide enhanced overall effectiveness by driving significant body weight reduction and optimizing glycemic control markers. Very clean product line and fast shipping.
Daniel Sanchez –
Integrating Ipamorelin alongside CJC-1295 (No DAC) in our testing protocol yielded exceptional synergy. Ipamorelin provided reliable support for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while CJC-1295 (No DAC) complemented the protocol perfectly by providing sharp, physiological growth hormone pulses when paired with a growth hormone secretagogue. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.
Rebecca Morris –
Our research team ran a 4-week protocol testing Ipamorelin together with CJC-1295 (No DAC). The results were noticeable from week one: Ipamorelin targeted providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while CJC-1295 (No DAC) enhanced overall effectiveness by providing sharp, physiological growth hormone pulses when paired with a growth hormone secretagogue. Very clean product line and fast shipping.
Catherine Turner –
Combining Ipamorelin with Survodutide has proven to be one of the most effective protocols in our catalog. Ipamorelin effectively handles providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Survodutide works in tandem to ensure boosting energy expenditure, promoting liver fat clearance, and controlling caloric intake. Consistent potency and exceptional quality.
Thomas Nelson –
Combining Ipamorelin and Tirzepatide created a remarkable dual-action response. We observed clean activation where Ipamorelin excelled at providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and Tirzepatide stepped in to deliver delivering powerful weight loss, insulin sensitivity improvements, and metabolic regulation. The purity of both compounds was top-notch with zero unexpected side effects.
Elizabeth Carter –
This combination of Ipamorelin and Dulaglutide exceeded expectations in our trial run. The inclusion of Ipamorelin was vital for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Dulaglutide amplified overall outcomes by providing long-acting glycemic control, metabolic stability, and appetite reduction. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
Debra Cook –
This combination of Ipamorelin and GHRP-2 exceeded expectations in our trial run. The inclusion of Ipamorelin was vital for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while GHRP-2 amplified overall outcomes by delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
Timothy Carter –
Combining Ipamorelin and CJC-1295 (With DAC) created a remarkable dual-action response. We observed clean activation where Ipamorelin excelled at providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and CJC-1295 (With DAC) stepped in to deliver sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life. The purity of both compounds was top-notch with zero unexpected side effects.
Rachel Morales –
Stacking Ipamorelin and Sermorelin provides a complete, well-rounded protocol. Ipamorelin acts as a baseline by providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, whereas Sermorelin adds synergistic value through stimulating natural pituitary GH output, enhancing recovery quality, supporting deep sleep, and overall vitality. Both vials dissolved effortlessly without residue.
Gregory Thompson –
Integrating Ipamorelin alongside Mazdutide in our testing protocol yielded exceptional synergy. Ipamorelin provided reliable support for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Mazdutide complemented the protocol perfectly by driving significant body weight reduction and optimizing glycemic control markers. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.
Dorothy Sanchez –
If you are looking to stack complementary peptides, pairing Ipamorelin with CJC-1295 + Ipamorelin Blend is an absolute winner. Ipamorelin shines for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and when stacked with CJC-1295 + Ipamorelin Blend, you gain the additional benefit of maximizing pulsatile growth hormone secretion via dual receptor pathway co-activation. Reconstitution was smooth and instantaneous.
Michelle Anderson –
Exceptional dual protocol. Using Ipamorelin in conjunction with Retatrutide + Cagrilintide Combo maximized total trial efficiency. Ipamorelin was key for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and Retatrutide + Cagrilintide Combo ensured delivering unmatched weight loss, appetite suppression, and metabolic energy balance. The batch purity report matched our independent verification completely.
Brenda Anderson –
Combining Ipamorelin and GHRP-6 created a remarkable dual-action response. We observed clean activation where Ipamorelin excelled at providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and GHRP-6 stepped in to deliver strongly stimulating growth hormone release while boosting appetite signaling and digestive motility. The purity of both compounds was top-notch with zero unexpected side effects.
Linda Phillips –
Integrating Ipamorelin alongside Cagrilintide in our testing protocol yielded exceptional synergy. Ipamorelin provided reliable support for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Cagrilintide complemented the protocol perfectly by promoting early satiety, delaying gastric emptying, and reducing food cravings independently of GLP-1. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.
Diane Flores –
Exceptional dual protocol. Using Ipamorelin in conjunction with GHRP-2 maximized total trial efficiency. Ipamorelin was key for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and GHRP-2 ensured delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile. The batch purity report matched our independent verification completely.
Brenda Collins –
Stacking Ipamorelin and Liraglutide provides a complete, well-rounded protocol. Ipamorelin acts as a baseline by providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, whereas Liraglutide adds synergistic value through supporting daily blood glucose stabilization, appetite control, and sustained weight management. Both vials dissolved effortlessly without residue.
Alexander Lopez –
Our research team ran a 4-week protocol testing Ipamorelin together with Hexarelin. The results were noticeable from week one: Ipamorelin targeted providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Hexarelin enhanced overall effectiveness by inducing rapid growth hormone pulses, supporting cardiac muscle health, and accelerating physical recovery. Very clean product line and fast shipping.
Michelle Parker –
Combining Ipamorelin with CJC-1295 + Ipamorelin Blend has proven to be one of the most effective protocols in our catalog. Ipamorelin effectively handles providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while CJC-1295 + Ipamorelin Blend works in tandem to ensure maximizing pulsatile growth hormone secretion via dual receptor pathway co-activation. Consistent potency and exceptional quality.
Rachel Lee –
Stacking Ipamorelin and CJC-1295 (With DAC) provides a complete, well-rounded protocol. Ipamorelin acts as a baseline by providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, whereas CJC-1295 (With DAC) adds synergistic value through sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life. Both vials dissolved effortlessly without residue.
Justin Hall –
Stacking Ipamorelin and GHRP-6 provides a complete, well-rounded protocol. Ipamorelin acts as a baseline by providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, whereas GHRP-6 adds synergistic value through strongly stimulating growth hormone release while boosting appetite signaling and digestive motility. Both vials dissolved effortlessly without residue.
Stephanie Diaz –
Our research team ran a 4-week protocol testing Ipamorelin together with HGH 191AA. The results were noticeable from week one: Ipamorelin targeted providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while HGH 191AA enhanced overall effectiveness by enhancing cellular regeneration, collagen synthesis, lean muscle preservation, and joint resilience. Very clean product line and fast shipping.
Jeffrey King –
If you are looking to stack complementary peptides, pairing Ipamorelin with Survodutide is an absolute winner. Ipamorelin shines for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and when stacked with Survodutide, you gain the additional benefit of boosting energy expenditure, promoting liver fat clearance, and controlling caloric intake. Reconstitution was smooth and instantaneous.
Kathleen Baker –
This combination of Ipamorelin and Semaglutide exceeded expectations in our trial run. The inclusion of Ipamorelin was vital for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Semaglutide amplified overall outcomes by effectively reducing appetite, suppressing cravings, and improving glycemic metrics. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
Maria Stewart –
Stacking Ipamorelin and Tirzepatide provides a complete, well-rounded protocol. Ipamorelin acts as a baseline by providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, whereas Tirzepatide adds synergistic value through delivering powerful weight loss, insulin sensitivity improvements, and metabolic regulation. Both vials dissolved effortlessly without residue.
Anthony Turner –
Combining Ipamorelin and Liraglutide created a remarkable dual-action response. We observed clean activation where Ipamorelin excelled at providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and Liraglutide stepped in to deliver supporting daily blood glucose stabilization, appetite control, and sustained weight management. The purity of both compounds was top-notch with zero unexpected side effects.
Frank Evans –
Exceptional dual protocol. Using Ipamorelin in conjunction with Dulaglutide maximized total trial efficiency. Ipamorelin was key for providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, and Dulaglutide ensured providing long-acting glycemic control, metabolic stability, and appetite reduction. The batch purity report matched our independent verification completely.
Frank Cooper –
Combining Ipamorelin with CagriSema (Cagrilintide + Semaglutide Combo) has proven to be one of the most effective protocols in our catalog. Ipamorelin effectively handles providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while CagriSema (Cagrilintide + Semaglutide Combo) works in tandem to ensure targeting dual satiety and hunger pathways for potent, comprehensive body weight management. Consistent potency and exceptional quality.
Larry Rogers –
Our research team ran a 4-week protocol testing Ipamorelin together with Cagrilintide. The results were noticeable from week one: Ipamorelin targeted providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite, while Cagrilintide enhanced overall effectiveness by promoting early satiety, delaying gastric emptying, and reducing food cravings independently of GLP-1. Very clean product line and fast shipping.